Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis

Journal of the Neurological Sciences

Volumn 249, Issue 2, 2006, Pages 145-152

  Warabi, Yoko ^a,b   Yagi, Kohichi ^a   Hayashi, Hideaki ^a   Matsumoto, Yoh ^b  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Complementarity determining region 3; EDSS; Multiple sclerosis; Neuromyelitis optica; T cell immunity; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CELL ACTIVITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MOLECULAR CLONING; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE;

ADULT; AGED; CLONE CELLS; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33750521145     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.06.011     Document Type: Article

References (24)

1. Mandler R.N., Davis L.E., Jeffery D.R., and Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34 (1993) 162-168
2. O'Riordan J.I., Gallagher H.L., Thompson A.J., Howard R.S., Kingsley D.P., Thompson E.J., et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60 (1996) 382-387
3. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., and Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 (1999) 1107-1114
4. Matsumoto Y., Yoon W.K., Jee Y., Fujihara K., Misu T., Sato S., et al. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol 170 (2003) 4846-4853
5. Shibasaki H., McDonald W.I., and Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 49 (1981) 253-271
6. Misu T., Fujihara K., Nakashima I., Miyazawa I., Okita N., Takase S., et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 125 (2002) 2460-2468
7. Yamasaki K., Horiuchi I., Minohara M., Kawano Y., Ohyagi Y., Yamada T., et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122 Pt 9 (1999) 1689-1696
8. Narikawa K., Misu T., Fujihara K., Nakashima I., Sato S., and Itoyama Y. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 149 (2004) 182-186
9. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
10. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
11. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
12. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
13. Choi Y.W., Kotzin B., Herron L., Callahan J., Marrack P., and Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A 86 (1989) 8941-8945
14. Kim G., Tanuma N., Kojima T., Kohyama K., Suzuki Y., Kawazoe Y., et al. CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis. J Immunol 160 (1998) 509-513
15. Matsumoto Y. Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines. J Neuroimmunol 110 (2000) 1-12
16. Kira J., Yamasaki K., Horiuchi I., Ohyagi Y., Taniwaki T., and Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 166 (1999) 53-57
17. Warabi Y., Yagi K., and Hayashi H. Multiple sclerosis in Tokyo Metropolitan Neurological Hospital: from the view points of north latitude and Japan's rapid economic growth. Rinsho Shinkeigaku 43 (2003) 432-433
18. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
19. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
20. Nakashima I., Fujihara K., and Itoyama Y. Oligoclonal IgG bands in Japanese multiple sclerosis patients. J Neuroimmunol 101 (1999) 205-206
21. Hong J., Zang Y.C., Tejada-Simon M.V., Kozovska M., Li S., Singh R.A., et al. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 163 (1999) 3530-3538
22. Demoulins T., Mouthon F., Clayette P., Bequet D., Gachelin G., and Dormont D. The same TCR (N)Dbeta(N)Jbeta junctional region is associated with several different vbeta13 subtypes in a multiple sclerosis patient at the onset of the disease. Neurobiol Dis 14 (2003) 470-482
23. Matsumoto Y., Jee Y., and Sugisaki M. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J Immunol 164 (2000) 2248-2254
24. Miyakoshi A., Yoon W.K., Jee Y., and Matsumoto Y. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats. J Immunol 170 (2003) 6371-6378